Dabur Chyawanprash, the flagship healthcare product from the House of Dabur, undertook a unique campaign, ‘Christened Immune India’, reaching out to over 10 lakh children across nine states to spread awareness about building stronger immunity to fight new-age diseases.
Metropolis Healthcare Ltd, India’s only multi-national chain of diagnostics centre, has developed a screening test to predict whether an individual is genetically predisposed to hereditary male and female pattern baldness.
Wockhardt Foundation has been conferred with the prestigious Pharma CSR Organisation of the Year Award, at ‘The Pharmaceutical Leadership Summit 2010’ held recently.
Veeda Oncology, a full service Oncology CRO with facilities in North America, Europe and India, has been awarded over USD 8.4 million of new clinical research programs.
Metropolis Healthcare Limited (Metropolis), India’s only multinational chain of diagnostic laboratories, announced that Warburg Pincus, a leading global private equity firm, is making an investment of up to USD 85 million in the company.
Recently launched neighbourhood Renal Disease Management Centre Nephrolife announced completing 2000 Dialysis since its inception of few months, in its technologically equipped centre located in Bangalore.
Neoretina Eye Care Institute (NEI), an exclusive tertiary hospital for Retinal Diseases Treatment and Comprehensive eye care was recently inaugurated by the Hon’ble Chief Minister of Andhra Pradesh, Shri K Rosaiah in Hyderabad.
The Chennai based Dr Kamakshi Memorial Hospital (KMH) performed a very rare heart surgery on a 20 year old girl from Basara, Iraq. She had complaints of breathing, combined with bouts of cough and pain in the chest.
Vipul Ltd, one of the leading realty companies in the country, has inked an agreement with Sankara Eye Care Institution, the largest chain of community eye-care institute in the country, to develop the 1st specialised eye-care hospital of Punjab.
HP Enterprise Services has announced of Alabama
US-based private equity firm New Enterprise Associates Inc. (NEA) is betting big on the Indian healthcare story as it eyes investments in specialty hospital chains. Globally, nearly 40% of its total assets under management of $11 billion is invested in healthcare-related sectors and it proposes to attach a similar significance to its play in India.
Fortis Healthcare Ltd has lined up its fund-raising plans as it prepares for a possible takeover battle for Singapore-based Parkway Holdings.
ICICI Venture, India’s largest private equity player, is looking at selling I-Ven Pharma Capital Limited, a Special Purpose Vehicle, to Dr Reddy’s Labs (DRL), its exclusive partner in the SPV.
